Mark Oette

2.5k total citations
66 papers, 1.1k citations indexed

About

Mark Oette is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mark Oette has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 30 papers in Virology and 21 papers in Epidemiology. Recurrent topics in Mark Oette's work include HIV Research and Treatment (29 papers), HIV/AIDS Research and Interventions (23 papers) and HIV/AIDS drug development and treatment (22 papers). Mark Oette is often cited by papers focused on HIV Research and Treatment (29 papers), HIV/AIDS Research and Interventions (23 papers) and HIV/AIDS drug development and treatment (22 papers). Mark Oette collaborates with scholars based in Germany, Slovakia and Austria. Mark Oette's co-authors include Dieter Häussinger, Rolf Kaiser, Gerd Fätkenheuer, Herbert Pfister, Martin Däumer, Jürgen K. Rockstroh, Abdurrahman Sagir, Arne Kroidl, Daniel Hoffmann and Björn‐Erik Ole Jensen and has published in prestigious journals such as Journal of Clinical Oncology, Spine and The Journal of Infectious Diseases.

In The Last Decade

Mark Oette

64 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Oette Germany 20 591 524 269 156 120 66 1.1k
Jean‐Marie Ragnaud France 20 692 1.2× 577 1.1× 273 1.0× 132 0.8× 404 3.4× 40 1.3k
Nicoletta Ladisa Italy 23 732 1.2× 543 1.0× 356 1.3× 108 0.7× 298 2.5× 69 1.2k
M Youle United Kingdom 23 829 1.4× 645 1.2× 672 2.5× 250 1.6× 126 1.1× 42 1.7k
Atsushi Ajisawa Japan 15 399 0.7× 152 0.3× 289 1.1× 101 0.6× 127 1.1× 70 834
Albrecht Stoehr Germany 20 738 1.2× 440 0.8× 627 2.3× 399 2.6× 148 1.2× 97 1.6k
Lambert Assoumou France 21 858 1.5× 842 1.6× 240 0.9× 70 0.4× 466 3.9× 78 1.4k
Djordje Jevtović Serbia 17 508 0.9× 275 0.5× 480 1.8× 56 0.4× 172 1.4× 98 1.0k
Carmela Pinnetti Italy 17 596 1.0× 300 0.6× 340 1.3× 44 0.3× 173 1.4× 91 921
Nathalie De Castro France 22 836 1.4× 314 0.6× 720 2.7× 388 2.5× 94 0.8× 75 1.6k
Patricia Price Australia 21 440 0.7× 404 0.8× 842 3.1× 94 0.6× 136 1.1× 52 1.5k

Countries citing papers authored by Mark Oette

Since Specialization
Citations

This map shows the geographic impact of Mark Oette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Oette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Oette more than expected).

Fields of papers citing papers by Mark Oette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Oette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Oette. The network helps show where Mark Oette may publish in the future.

Co-authorship network of co-authors of Mark Oette

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Oette. A scholar is included among the top collaborators of Mark Oette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Oette. Mark Oette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schommers, Philipp, Daniel Gillor, Marcus Hentrich, et al.. (2018). Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study. Haematologica. 103(5). 857–864. 22 indexed citations
2.
Jensen, Björn‐Erik Ole, et al.. (2017). HIV-Associated Gastrointestinal Cancer. Oncology Research and Treatment. 40(3). 115–118. 10 indexed citations
3.
Oette, Mark, Stefan Reuter, Rolf Kaiser, et al.. (2012). Epidemiology of Transmitted Drug Resistance in Chronically HIV-Infected Patients in Germany: The RESINA Study 2001–2009. Intervirology. 55(2). 154–159. 13 indexed citations
4.
Lawyer, Glenn, Eugen Schülter, Rolf Kaiser, et al.. (2012). Endogenous or exogenous spreading of HIV-1 in Nordrhein-Westfalen, Germany, investigated by phylodynamic analysis of the RESINA Study cohort. Medical Microbiology and Immunology. 201(3). 259–269. 5 indexed citations
5.
Schülter, Eugen, Mark Oette, Stefan Reuter, et al.. (2011). HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, Germany. Medical Microbiology and Immunology. 200(4). 219–223. 13 indexed citations
6.
Sierra, Saleta, Rolf Kaiser, Nadine Lübke, et al.. (2011). Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach. Journal of Visualized Experiments. 14 indexed citations
7.
Reuter, Stefan, et al.. (2010). Changes in the HIV‐1 mutational profile before first‐line HAART in the RESINA cohort. Journal of Medical Virology. 83(2). 187–195. 2 indexed citations
8.
Reuter, Stefan, Mark Oette, Rolf Kaiser, et al.. (2010). Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients. Medical Microbiology and Immunology. 200(1). 39–49. 23 indexed citations
9.
Oette, Mark, Klaus Göbels, M Wettstein, et al.. (2009). Wireless capsule endoscopy for the detection of small bowel diseases in HIV-1-infected patients. European journal of medical research. 14(5). 191–4. 4 indexed citations
10.
Sagir, Abdurrahman, et al.. (2007). Therapy outcome in patients with chronic hepatitis C: role of therapy supervision by expert hepatologists. Journal of Viral Hepatitis. 14(9). 633–638. 4 indexed citations
11.
Sagir, Abdurrahman, Mark Oette, Rolf Kaiser, et al.. (2007). Trends of prevalence of primary HIV drug resistance in Germany. Journal of Antimicrobial Chemotherapy. 60(4). 843–848. 44 indexed citations
12.
Oette, Mark, Rolf Kaiser, Martin Däumer, et al.. (2007). Epidemiologie der primären Medikamentenresistenz bei chronisch HIV-Infizierten in Nordrhein-Westfalen 2001-2005. DMW - Deutsche Medizinische Wochenschrift. 132(18). 977–982. 6 indexed citations
13.
Sagir, Abdurrahman, et al.. (2007). Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection. Liver International. 27(7). 954–959. 4 indexed citations
14.
Hentrich, Marcus, Kai Uwe Chow, Johannes R. Bogner, et al.. (2006). Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study. Annals of Oncology. 17(6). 914–919. 38 indexed citations
15.
Göbels, Klaus, et al.. (2006). HIV-HBV-Koinfektion - Diagnostik und Therapie. DMW - Deutsche Medizinische Wochenschrift. 131(34/35). 1873–1877. 2 indexed citations
16.
Oette, Mark, et al.. (2005). Case Report: Acute Syphilitic Blindness in an HIV-Positive Patient. AIDS Patient Care and STDs. 19(4). 209–211. 10 indexed citations
17.
Sagir, Abdurrahman, Ortwin Adams, Mark Oette, et al.. (2005). SEN virus has an adverse effect on the survival of HIV-positive patients. AIDS. 19(10). 1091–1096. 10 indexed citations
18.
Häussinger, Dieter, Andreas Erhardt, & Mark Oette. (2004). Koinfektionen bei Hepatitis. Zeitschrift für Gastroenterologie. 42(8). 724–730. 1 indexed citations
19.
Sagir, Abdurrahman, Ortwin Adams, Mark Oette, et al.. (2004). SEN virus seroprevalence in HIV positive patients: association with immunosuppression and HIV-replication. Journal of Clinical Virology. 33(3). 183–187. 8 indexed citations
20.
Oette, Mark, Arne Kroidl, Abdurrahman Sagir, et al.. (2002). Lipodystrophy Syndrome and Self-Assessment of Well-Being and Physical Appearance in HIV-Positive Patients. AIDS Patient Care and STDs. 16(9). 413–417. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Marie Ragnaud Breakdown of academic impact, for papers by Nicoletta Ladisa Breakdown of academic impact, for papers by M Youle Breakdown of academic impact, for papers by Atsushi Ajisawa Breakdown of academic impact, for papers by Albrecht Stoehr Breakdown of academic impact, for papers by Lambert Assoumou Breakdown of academic impact, for papers by Djordje Jevtović Breakdown of academic impact, for papers by Carmela Pinnetti Breakdown of academic impact, for papers by Nathalie De Castro Breakdown of academic impact, for papers by Patricia Price
Rankless by CCL
2026